Rich Pharmaceuticals Inc. announced this week that CMIC ASIA-PACIFIC PTD. LTD., an Asian contract research organization (CRO), will run the first phase of an upcoming oncology clinical. Read More »

GlaxoSmithKline (GSK) has announced the approval of Nucala (mepolizumab) by the Japanese Ministry of Health Labor and Welfare (MHLW). Read More »

CVS Health has announced that its specialty pharmacy, CVS Specialty, has been awarded Specialty Pharmacy accreditation from URAC. Read More »

The Children’s Miracle Network Hospitals has announced that it will be entering a collaborative effort with the United Networks of America (UNA). Read More »

One pharmaceutical company executive stated that the challenges retail and outpatient pharmacies face in regards to the reimbursement and regulatory environment can be solved by technology. Read More »

Pfizer has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved a new presentation of Prevenar 13 (pneumococcal polysaccharide conjugate vaccine [13-valent, absorbed]). Read More »

The American Society of Health-System Pharmacists (ASHP) has acknowledged the accomplishments of 11 pharmacy students for their leadership on campus and in the pharmacy practice setting by awarding them with the ASHP Student Leadership Award. Read More »

Victims of digestive disorders, arthritis and psoriasis are one step closer to relief as of April 5, when the U.S. Food and Drug Administration approved Inflectra to address Crohn’s, colitis, and other chronic ailments. Read More »

The U.S. Food and Drug Administration (FDA) has approved Celltrion’s INFLECTRA (biosimilar infliximab) for all qualified indications of the reference product, Remicade (infliximab). Read More »

The Cardinal Health Foundation and The Ohio State University College of Pharmacy honored student pharmacists nationwide and a clinical professor of pharmacy as part of the Generation Rx education and outreach initiative. Read More »

Pfizer and IBM announced today a novel research partnership that will lead to the development of groundbreaking remote monitoring solutions focused on revolutionizing the care Parkinson’s patients receive. Read More »

Allergan, a worldwide leading pharmaceutical company, and Sosei Group Corp. subsidiary, Heptares Therapeutics, have announced that Allergan Pharmaceuticals International Limited, an Allergan subsidiary, and Heptares have an agreement in place that will give Allegran exclusive worldwide licensing rights to a wide variety of novel subtype-selective muscarinic receptor agonists that are currently in development. Read More »

The new officers for the American Pharmacists Association (APhA) 2016-17 Board of Directors have been selected. Read More »

The American Society of Health-System Pharmacists (ASHP) second Match program concluded this week, with 4,273 individuals matched with more than 2,000 pharmacy residency programs nationwide. Read More »

TeaserHealth care benefits company Aetna has recently entered into an agreement with Abington Medical Specialists/AMS Cardiology in an effort to provide individuals with quality care at an affordable cost.HeadlineAetna enters into five-year deal with AMS CardiologyBodyHealth care benefits company Aetna has recently entered into an agreement with Abington Medical Specialists/AMS Cardiology in an effort to provide individuals with quality care at an affordable cost.Aetna is transforming health car Read More »

Allergan, a worldwide leader in the development of treatments design to combat infectious diseases, has released new data from its anti-infective portfolio. Read More »

McKesson recently announced that it has been awarded a $139 million, five-year contract from the Department of Defense and the Defense Health Agency for its patient engagement and interoperable secure messaging solution, RelayHealth. Read More »

NACDS and NCPA urge Congress to reduce TRICARE costs. Read More »

Amgen recently announced its win against Sanofi and Regeneron Pharmaceuticals. Read More »

Potential treatment for early Alzheimer's disease to continue without modification to Phase III. Read More »